Brisk Walking and Baduanjin Improve Inhibitory Function in Older Adults With Cognitive Impairment
NCT07678476, Not applicable, Completed, Shanghai University of Sport
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Brisk Walking and Baduanjin Improve Inhibitory Function in Older Adults With Cognitive Impairment | ClinicalTrials.gov |
| NCT number | NCT07678476 | ClinicalTrials.gov |
| Status | Completed | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 45 participants, actual | ClinicalTrials.gov |
| Lead sponsor | Shanghai University of Sport | ClinicalTrials.gov |
| Conditions | Cognition Impairment | ClinicalTrials.gov |
| Interventions | exercise intervention | ClinicalTrials.gov |
| First posted | 2026-07-01 | ClinicalTrials.gov |
| Last updated | 2026-08-11 | ClinicalTrials.gov |
Registered outcomes 3
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Change in Inhibitory Function Assessed by the Stroop Color-Word Test | Baseline and immediately post-intervention (approximately 30 minutes after the exercise session) | Inhibitory function will be assessed using the Stroop color-word test. Participants are required to name the color of the ink while inhibiting the automatic tendency to read the word. The outcome measure is the change from baseline in accuracy rate (%) under both congruent and incongruent conditions immediately post-intervention. | ClinicalTrials.gov |
| Primary | Change in Inhibitory Function Assessed by the Stroop Color-Word Test | Baseline and immediately post-intervention (approximately 30 minutes after the exercise session | Inhibitory function will be assessed using the Stroop color-word test. Participants are required to name the color of the ink while inhibiting the automatic tendency to read the word. The outcome measure is the change from baseline in reaction time (milliseconds) under both congruent and incongruent conditions immediately post-intervention. | ClinicalTrials.gov |
| Secondary | Change in Resting-State EEG Power Spectrum | Baseline and immediately post-intervention (approximately 30 minutes after the exercise session) | Resting-state electroencephalography (EEG) will be recorded for 5 minutes with eyes closed. The outcome measure is the change from baseline in absolute power across multiple frequency bands: delta (1-4 Hz), theta (4-8 Hz), alpha (8-12 Hz), and beta (12-30 Hz). EEG power will be calculated for five brain regions (frontal, central, temporal, parietal, and occipital). | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 0
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 1
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Stroop Color-Word Test | Primary outcome | ConductCognition |
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)